Mp-tscpc System
Mp-tscpc System - Related Videos
01:30
Marginal Propensity to Consume
0 Views •
2025
The marginal propensity to consume (MPC) describes how much of an additional dollar of disposable income a household is likely to spend rather than save. It provides insight into consumer behavior and is a foundational component in the analysis of fiscal policy effectiveness and national income determination.Concept and MeasurementMPC is measured as the ratio of the change in consumption (ΔC) to the change in disposable income (ΔY), expressed as:MPC = ΔC / ΔYFor example, if an individual's...
14:18
Synthesis, Assembly, and Characterization of Monolayer Protected Gold Nanoparticle Films for Protein Monolayer Electrochemistry
0 Views •
Cited by 1 •
2011
Alkanethiolate stabilized gold colloids known as monolayer protected clusters (MPCs) are synthesized, characterized, and assembled into thin films as an adsorption interface for protein monolayer electrochemistry of simple redox protein like Pseudomonas aeruginosa azurin (AZ) and cytochrome c (cyt c).
09:53
Isolating Mesangiogenic Progenitor Cells (MPCs) from Human Bone Marrow
0 Views •
Cited by 17 •
2016
Here we describe an optimized, highly reproducible protocol to isolate Mesodermal Progenitor Cells (MPCs) from human bone marrow (hBM). MPCs were characterized by flow cytometry and nestin expression. They showed the ability to give rise to exponentially growing MSC-like cell cultures while retaining their angiogenic potential.
10:46
Isolation and Culture of Pulmonary Endothelial Cells from Neonatal Mice
0 Views •
Cited by 89 •
2010
Here, we describe a protocol for isolation and culture of murine pulmonary endothelial cells. This method comprises mechanic and enzymatic lung tissue dissociation as well as a 2-step purification process using anti-PECAM-1 and anti-ICAM-2 antibodies conjugated to magnetic beads, which produces a pure endothelial cell population of mostly microvascular origin.
10:36
Chromatin Immunoprecipitation from Human Embryonic Stem Cells
0 Views •
Cited by 6 •
2008
The differentiation of ESC coincides with cell-type specific changes in the structure and composition of chromatin. The detection of those changes provides valuable insights into the mechanisms that define stemcellness and cell differentiation. Chromatin immunoprecipitation (ChIP) represents a valuable method to dissect the molecular mechanisms underlying stem cell differentiation.
FAQs
The probe delivers laser energy in repeated micropulses rather than as one uninterrupted exposure. Each burst is followed by a cooling interval, so the treatment can act on the ciliary body while reducing the duration of continuous heat delivered to nearby tissues. This design is central to the system’s tissue-sparing approach and distinguishes it from continuous energy delivery.
The ciliary body contributes to aqueous humor production, and the amount of aqueous humor influences intraocular pressure. MP-TSCPC applies energy through the sclera to this structure, reducing aqueous humor production and thereby supporting pressure lowering. This mechanism explains why the platform is directed at the ciliary body rather than used as a general treatment across the eye.
Unlike incisional procedures, the system reaches the treatment target through the sclera without creating an incision. Its micropulsed pattern also differs from continuous laser exposure because cooling intervals interrupt energy delivery. Together, these features provide a nonincisional approach to ciliary-body treatment while limiting continuous heat exposure to surrounding ocular tissues.
MP-TSCPC is especially relevant when glaucoma-related intraocular pressure remains difficult to control with medications or conventional procedures. The system is also associated with managing complex or refractory disease, where additional pressure-management options may be needed. It therefore serves as an option within the broader treatment approach for challenging glaucoma cases.
At a conceptual level, treatment consists of positioning the system’s probe against the scleral surface, directing diode-laser energy toward the ciliary body, and delivering that energy as repeated micropulses. The bursts are separated by cooling intervals during exposure. These steps preserve the system’s transscleral, nonincisional route while focusing treatment on the pressure-related target.
The essential treatment components are the MP-TSCPC platform, its probe, a diode-laser source, and the scleral route to the ciliary body. The probe serves as the delivery interface, while the laser supplies micropulsed energy. This combination allows clinicians to apply targeted treatment externally rather than access the ciliary body through an incision.
The immediate therapeutic objective is lower intraocular pressure through reduced aqueous humor production. In clinical context, that pressure-management goal is most important for patients whose glaucoma remains challenging despite medications or conventional procedures. The system expands available options by combining ciliary-body treatment with a nonincisional approach, which is particularly relevant in complex or refractory disease.